ArticleJPRAS open2026
Aesthetic surgery complications in private practice settings: Insights to optimize patient access and outcomes.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Complications of aesthetic surgery performed in private practice pose significant risk to patients and resource burden to healthcare systems. Thorough understanding of this population is important to mitigate future complications. We evaluated demographic and complication patterns among patients presenting to our institution after aesthetic surgery, and the financial liability of their care on the hospital and payor. Methods: This was a retrospective chart review of patients with complications related to aesthetic procedures from 2020-2023. Extracted data include biologic sex, age, smoking status, geographic location of original procedure, index surgical complications, timing of presentation, imaging, length of hospital admission, hospital charges, and insurance payments. Univariable analyses identified associations with outcomes. Results: A total 36 patients were included (mean age: 37.5 years). Patients were more likely to be Black (p = 0.04), Hispanic (p = 0.03), and on Medicaid (p < 0.001). Tobacco/cannabis use and obesity were prevalent in 25% and 47.2% of patients, respectively. Nearly half of patients had their procedures in Mexico (36.1%) and the Dominican Republic (11.4%). Patients using tobacco/cannabis were more likely to present with infection (p = 0.001) and undergo intervention (p = 0.01). The total median hospital charge was $43,324.96 (IQR $10,728.12, $80,803.18) and median insurance payment was $3947 (IQR $404.61, $24,516.00). In cases involving operative intervention, median hospital charge and insurance payments were $125,358.70 (IQR $51,065.52, $152,704.70) and $14,863.52 (IQR $3947, $49,031.13), respectively. Conclusion: There is a disproportionate number of patients from socioeconomically disadvantaged backgrounds who present with aesthetic complications and incur substantial costs, prompting the need for interventions that promote safe, equitable access to aesthetic procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.